The UK clinical eye research strategy: refreshing research priorities for clinical eye research in the UK

Objectives: To validate and update the 2013 James Lind Alliance (JLA) Sight Loss and Vision Priority Setting Partnership (PSP)’s research priorities for Ophthalmology, as part of the UK Clinical Eye Research Strategy. Methods: Twelve ophthalmology research themes were identified from the JLA report....

Full description

Bibliographic Details
Main Authors: Bourne, RRA, Moledina, M, Azuara-Blanco, A, Saleh, GM, Self, JE, Sivaprasad, S, Sharma, SM, Ross, A, Gilbert, RM, Abdalla Elsayed, MEA, Moon, WY, Doug, M, Mulholland, PJ, Day, AC, Romano, V, Hoad, GV, Kara, M, Murray, A, Gow, L, Ghanchi, F, Patel, PJ, Gale, RP, Dinah, C, Valentine, K
Format: Journal article
Language:English
Published: Springer Nature [academic journals on nature.com] 2024
_version_ 1826314815156518912
author Bourne, RRA
Moledina, M
Azuara-Blanco, A
Saleh, GM
Self, JE
Sivaprasad, S
Sharma, SM
Ross, A
Gilbert, RM
Abdalla Elsayed, MEA
Moon, WY
Doug, M
Mulholland, PJ
Day, AC
Romano, V
Hoad, GV
Kara, M
Murray, A
Gow, L
Ghanchi, F
Patel, PJ
Gale, RP
Dinah, C
Valentine, K
author_facet Bourne, RRA
Moledina, M
Azuara-Blanco, A
Saleh, GM
Self, JE
Sivaprasad, S
Sharma, SM
Ross, A
Gilbert, RM
Abdalla Elsayed, MEA
Moon, WY
Doug, M
Mulholland, PJ
Day, AC
Romano, V
Hoad, GV
Kara, M
Murray, A
Gow, L
Ghanchi, F
Patel, PJ
Gale, RP
Dinah, C
Valentine, K
author_sort Bourne, RRA
collection OXFORD
description Objectives: To validate and update the 2013 James Lind Alliance (JLA) Sight Loss and Vision Priority Setting Partnership (PSP)’s research priorities for Ophthalmology, as part of the UK Clinical Eye Research Strategy. Methods: Twelve ophthalmology research themes were identified from the JLA report. They were allocated to five Clinical Study Groups of diverse stakeholders who reviewed the top 10 research priorities for each theme. Using an online survey (April 2021-February 2023), respondents were invited to complete one or more of nine subspecialty surveys. Respondents indicated which of the research questions they considered important and subsequently ranked them. Results: In total, 2240 people responded to the survey (mean age, 59.3 years), from across the UK. 68.1% were female. 68.2% were patients, 22.3% healthcare professionals or vision researchers, 7.1% carers, and 2.1% were charity support workers. Highest ranked questions by subspecialty: Cataract (prevention), Cornea (improving microbial keratitis treatment), Optometric (impact of integration of ophthalmic primary and secondary care via community optometric care pathways), Refractive (factors influencing development and/or progression of refractive error), Childhood onset (improving early detection of visual disorders), Glaucoma (effective and improved treatments), Neuro-ophthalmology (improvements in prevention, diagnosis and treatment of neurodegeneration affecting vision), Retina (improving prevention, diagnosis and treatment of dry age-related macular degeneration), Uveitis (effective treatments for ocular and orbital inflammatory diseases). Conclusions: A decade after the initial PSP, the results refocus the most important research questions for each subspecialty, and prime targeted research proposals within Ophthalmology, a chronically underfunded specialty given the substantial burden of disability caused by eye disease.
first_indexed 2024-09-25T04:13:25Z
format Journal article
id oxford-uuid:20e40a49-f41e-4dab-bf72-711d6dfa6583
institution University of Oxford
language English
last_indexed 2024-12-09T03:13:47Z
publishDate 2024
publisher Springer Nature [academic journals on nature.com]
record_format dspace
spelling oxford-uuid:20e40a49-f41e-4dab-bf72-711d6dfa65832024-10-16T09:26:51ZThe UK clinical eye research strategy: refreshing research priorities for clinical eye research in the UKJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:20e40a49-f41e-4dab-bf72-711d6dfa6583EnglishJisc Publications RouterSpringer Nature [academic journals on nature.com]2024Bourne, RRAMoledina, MAzuara-Blanco, ASaleh, GMSelf, JESivaprasad, SSharma, SMRoss, AGilbert, RMAbdalla Elsayed, MEAMoon, WYDoug, MMulholland, PJDay, ACRomano, VHoad, GVKara, MMurray, AGow, LGhanchi, FPatel, PJGale, RPDinah, CValentine, KObjectives: To validate and update the 2013 James Lind Alliance (JLA) Sight Loss and Vision Priority Setting Partnership (PSP)’s research priorities for Ophthalmology, as part of the UK Clinical Eye Research Strategy. Methods: Twelve ophthalmology research themes were identified from the JLA report. They were allocated to five Clinical Study Groups of diverse stakeholders who reviewed the top 10 research priorities for each theme. Using an online survey (April 2021-February 2023), respondents were invited to complete one or more of nine subspecialty surveys. Respondents indicated which of the research questions they considered important and subsequently ranked them. Results: In total, 2240 people responded to the survey (mean age, 59.3 years), from across the UK. 68.1% were female. 68.2% were patients, 22.3% healthcare professionals or vision researchers, 7.1% carers, and 2.1% were charity support workers. Highest ranked questions by subspecialty: Cataract (prevention), Cornea (improving microbial keratitis treatment), Optometric (impact of integration of ophthalmic primary and secondary care via community optometric care pathways), Refractive (factors influencing development and/or progression of refractive error), Childhood onset (improving early detection of visual disorders), Glaucoma (effective and improved treatments), Neuro-ophthalmology (improvements in prevention, diagnosis and treatment of neurodegeneration affecting vision), Retina (improving prevention, diagnosis and treatment of dry age-related macular degeneration), Uveitis (effective treatments for ocular and orbital inflammatory diseases). Conclusions: A decade after the initial PSP, the results refocus the most important research questions for each subspecialty, and prime targeted research proposals within Ophthalmology, a chronically underfunded specialty given the substantial burden of disability caused by eye disease.
spellingShingle Bourne, RRA
Moledina, M
Azuara-Blanco, A
Saleh, GM
Self, JE
Sivaprasad, S
Sharma, SM
Ross, A
Gilbert, RM
Abdalla Elsayed, MEA
Moon, WY
Doug, M
Mulholland, PJ
Day, AC
Romano, V
Hoad, GV
Kara, M
Murray, A
Gow, L
Ghanchi, F
Patel, PJ
Gale, RP
Dinah, C
Valentine, K
The UK clinical eye research strategy: refreshing research priorities for clinical eye research in the UK
title The UK clinical eye research strategy: refreshing research priorities for clinical eye research in the UK
title_full The UK clinical eye research strategy: refreshing research priorities for clinical eye research in the UK
title_fullStr The UK clinical eye research strategy: refreshing research priorities for clinical eye research in the UK
title_full_unstemmed The UK clinical eye research strategy: refreshing research priorities for clinical eye research in the UK
title_short The UK clinical eye research strategy: refreshing research priorities for clinical eye research in the UK
title_sort uk clinical eye research strategy refreshing research priorities for clinical eye research in the uk
work_keys_str_mv AT bournerra theukclinicaleyeresearchstrategyrefreshingresearchprioritiesforclinicaleyeresearchintheuk
AT moledinam theukclinicaleyeresearchstrategyrefreshingresearchprioritiesforclinicaleyeresearchintheuk
AT azuarablancoa theukclinicaleyeresearchstrategyrefreshingresearchprioritiesforclinicaleyeresearchintheuk
AT salehgm theukclinicaleyeresearchstrategyrefreshingresearchprioritiesforclinicaleyeresearchintheuk
AT selfje theukclinicaleyeresearchstrategyrefreshingresearchprioritiesforclinicaleyeresearchintheuk
AT sivaprasads theukclinicaleyeresearchstrategyrefreshingresearchprioritiesforclinicaleyeresearchintheuk
AT sharmasm theukclinicaleyeresearchstrategyrefreshingresearchprioritiesforclinicaleyeresearchintheuk
AT rossa theukclinicaleyeresearchstrategyrefreshingresearchprioritiesforclinicaleyeresearchintheuk
AT gilbertrm theukclinicaleyeresearchstrategyrefreshingresearchprioritiesforclinicaleyeresearchintheuk
AT abdallaelsayedmea theukclinicaleyeresearchstrategyrefreshingresearchprioritiesforclinicaleyeresearchintheuk
AT moonwy theukclinicaleyeresearchstrategyrefreshingresearchprioritiesforclinicaleyeresearchintheuk
AT dougm theukclinicaleyeresearchstrategyrefreshingresearchprioritiesforclinicaleyeresearchintheuk
AT mulhollandpj theukclinicaleyeresearchstrategyrefreshingresearchprioritiesforclinicaleyeresearchintheuk
AT dayac theukclinicaleyeresearchstrategyrefreshingresearchprioritiesforclinicaleyeresearchintheuk
AT romanov theukclinicaleyeresearchstrategyrefreshingresearchprioritiesforclinicaleyeresearchintheuk
AT hoadgv theukclinicaleyeresearchstrategyrefreshingresearchprioritiesforclinicaleyeresearchintheuk
AT karam theukclinicaleyeresearchstrategyrefreshingresearchprioritiesforclinicaleyeresearchintheuk
AT murraya theukclinicaleyeresearchstrategyrefreshingresearchprioritiesforclinicaleyeresearchintheuk
AT gowl theukclinicaleyeresearchstrategyrefreshingresearchprioritiesforclinicaleyeresearchintheuk
AT ghanchif theukclinicaleyeresearchstrategyrefreshingresearchprioritiesforclinicaleyeresearchintheuk
AT patelpj theukclinicaleyeresearchstrategyrefreshingresearchprioritiesforclinicaleyeresearchintheuk
AT galerp theukclinicaleyeresearchstrategyrefreshingresearchprioritiesforclinicaleyeresearchintheuk
AT dinahc theukclinicaleyeresearchstrategyrefreshingresearchprioritiesforclinicaleyeresearchintheuk
AT valentinek theukclinicaleyeresearchstrategyrefreshingresearchprioritiesforclinicaleyeresearchintheuk
AT bournerra ukclinicaleyeresearchstrategyrefreshingresearchprioritiesforclinicaleyeresearchintheuk
AT moledinam ukclinicaleyeresearchstrategyrefreshingresearchprioritiesforclinicaleyeresearchintheuk
AT azuarablancoa ukclinicaleyeresearchstrategyrefreshingresearchprioritiesforclinicaleyeresearchintheuk
AT salehgm ukclinicaleyeresearchstrategyrefreshingresearchprioritiesforclinicaleyeresearchintheuk
AT selfje ukclinicaleyeresearchstrategyrefreshingresearchprioritiesforclinicaleyeresearchintheuk
AT sivaprasads ukclinicaleyeresearchstrategyrefreshingresearchprioritiesforclinicaleyeresearchintheuk
AT sharmasm ukclinicaleyeresearchstrategyrefreshingresearchprioritiesforclinicaleyeresearchintheuk
AT rossa ukclinicaleyeresearchstrategyrefreshingresearchprioritiesforclinicaleyeresearchintheuk
AT gilbertrm ukclinicaleyeresearchstrategyrefreshingresearchprioritiesforclinicaleyeresearchintheuk
AT abdallaelsayedmea ukclinicaleyeresearchstrategyrefreshingresearchprioritiesforclinicaleyeresearchintheuk
AT moonwy ukclinicaleyeresearchstrategyrefreshingresearchprioritiesforclinicaleyeresearchintheuk
AT dougm ukclinicaleyeresearchstrategyrefreshingresearchprioritiesforclinicaleyeresearchintheuk
AT mulhollandpj ukclinicaleyeresearchstrategyrefreshingresearchprioritiesforclinicaleyeresearchintheuk
AT dayac ukclinicaleyeresearchstrategyrefreshingresearchprioritiesforclinicaleyeresearchintheuk
AT romanov ukclinicaleyeresearchstrategyrefreshingresearchprioritiesforclinicaleyeresearchintheuk
AT hoadgv ukclinicaleyeresearchstrategyrefreshingresearchprioritiesforclinicaleyeresearchintheuk
AT karam ukclinicaleyeresearchstrategyrefreshingresearchprioritiesforclinicaleyeresearchintheuk
AT murraya ukclinicaleyeresearchstrategyrefreshingresearchprioritiesforclinicaleyeresearchintheuk
AT gowl ukclinicaleyeresearchstrategyrefreshingresearchprioritiesforclinicaleyeresearchintheuk
AT ghanchif ukclinicaleyeresearchstrategyrefreshingresearchprioritiesforclinicaleyeresearchintheuk
AT patelpj ukclinicaleyeresearchstrategyrefreshingresearchprioritiesforclinicaleyeresearchintheuk
AT galerp ukclinicaleyeresearchstrategyrefreshingresearchprioritiesforclinicaleyeresearchintheuk
AT dinahc ukclinicaleyeresearchstrategyrefreshingresearchprioritiesforclinicaleyeresearchintheuk
AT valentinek ukclinicaleyeresearchstrategyrefreshingresearchprioritiesforclinicaleyeresearchintheuk